Trial · NCT05051735
PARASTOP - Paracetamol With Strong Opioids
NCT05051735, Phase 3, Completed, Oslo University Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. PARASTOP - Paracetamol With Strong Opioids. Trials, record NCT05051735. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05051735
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- PARASTOP - Paracetamol With Strong Opioids
- NCT number
- NCT05051735
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 204 participants, actual
- Lead sponsor
- Oslo University Hospital
- Conditions
- Cancer Pain, Cancer
- Interventions
- Paracetamol, Placebo
- First posted
- 2021-09-21
- Last updated
- 2026-02-25
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | To establish whether placebo with strong opioids compared to paracetamol together with strong opioids provides non-inferior analgesia for cancer-related pain. | 7 days | Numeric Rating Scale 0-10: Average pain intensity past 24 hours |
| Secondary | To establish whether placebo with strong opioids compared to paracetamol with strong opioids changes opioid related side effects. | 7 days | Opioid Side Effects Questionnaire |
| Secondary | To establish whether placebo with strong opioids compared to paracetamol with strong opioids changes global rating of improvement. | 7 days | Patient Global Impression of Change |
| Secondary | To establish whether placebo with strong opioids compared to paracetamol with strong opioids changes opioid requirements. | 7 days | Opioid consumption |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05051735
GET https://conductscience.org/api/trials/v1/NCT05051735/registered